AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Moxgic-CV 625 Tablet

Prescription Icon
Prescription Required

Marketer

Alegic Pharmaceuticals Pvt Ltd

Salt Composition

Amoxycillin (500mg) + Clavulanic Acid (125mg)

Overview Moxgic-CV 625 Tablet

Augmentin-equivalent 625mg tablets combat bacterial infections. This antibiotic treats lung (pneumonia, for example), ear, sinus, urinary tract, skin, and soft tissue infections. It's ineffective against viral illnesses like the common cold. To minimize stomach discomfort, take this medication with food, following your doctor's prescribed schedule for consistent, evenly-spaced doses. Daily adherence at the same time improves compliance. Dosage varies by infection; complete the full course as directed, even if symptoms improve. Premature discontinuation risks infection recurrence or worsening. Common mild side effects include nausea, diarrhea, vomiting, oral or genital yeast infections, skin rashes, and vaginitis. Report persistent or bothersome side effects to your physician. Prior to use, disclose any antibiotic allergies, kidney or liver issues, and all other medications to your doctor or healthcare provider, as interactions are possible. Generally considered safe during pregnancy and breastfeeding under medical supervision.

Uses of Moxgic-CV 625 Tablet

Treatment of Bacterial infections

Major Benefits of Moxgic-CV 625 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Moxgic-CV 625 Tablets should be administered with a meal.

Common Side effects of Moxgic-CV 625 Tablet:

  • Vaginal inflammation
  • Mucocutaneous candidiasis
  • Vomiting
  • Nausea
  • Diarrhea
  • Skin rash
  • Red spots or bumps
  • Fungal infection

How to use Moxgic-CV 625 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Moxgic-CV 625 Tablets should be administered with food.

How Moxgic-CV 625 Tablet works:

Moxgic-CV 625 Tablet is a combination of two medicines: Amoxycillin and Clavulanic Acid. Amoxycillin is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Amoxycillin against bacteria.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingesting alcohol alongside Moxgic-CV 625 Tablets poses no known adverse reactions.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Moxgic-CV 625 Tablets during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Use of Moxgic-CV 625 Tablet while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Moxgic-CV 625 Tablet side effects, including allergic reactions, dizziness, or seizures.

KidneyKidneyCAUTION

Patients with kidney impairment should use Moxgic-CV 625 Tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Moxgic-CV 625 Tablets are contraindicated in patients with severe kidney disease.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Moxgic-CV 625 Tablets, as dosage modification may be necessary. Physician consultation is advised. Routine liver function assessments are recommended during treatment.

What if you forget to take Moxgic-CV 625 Tablet :

Should you forget a Moxgic-CV 625 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Moxgic-CV 625 Tablet

LabelValue
Addictive None.
Medication Category Agents against infection

FAQs on Moxgic-CV 625 Tablet

Amoxycillin and clavulanic acid, combined as Moxgic-CV 625 Tablet, combat bacterial infections. These infections may include tonsillitis, sinusitis, otitis media, respiratory and urinary tract infections, boils, abscesses, cellulitis, wound and bone infections, and oral cavity infections. Its mechanism involves eliminating the bacteria responsible for the infection.
Following prescribed dosages, Moxgic-CV 625 Tablet is generally well-tolerated. Nevertheless, some individuals may experience typical side effects such as nausea, vomiting, diarrhea, rash, or allergic reactions, along with less frequent or infrequent adverse events. Promptly consult your physician should any treatment-related issue persist.
Patients allergic to penicillin or any Moxgic-CV 625 Tablet component should avoid this medication. Its use is contraindicated in individuals with a history of hepatic impairment. Report any medication allergies to your physician.
Taking Moxgic-CV 625 Tablet may reduce the effectiveness of oral contraceptives. It's crucial to discuss alternative birth control options, such as condoms, diaphragms, or spermicides, with your physician before and during treatment with Moxgic-CV 625 Tablet.
Exceeding the prescribed dosage of Moxgic-CV 625 Tablet elevates the probability of adverse reactions. Therapeutic efficacy from Moxgic-CV 625 Tablet develops gradually; worsening symptoms necessitate a physician's consultation for reassessment.
Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any unused medication properly and prevent access by children, pets, and other individuals.
Discontinue Moxgic-CV 625 Tablet only after finishing the prescribed treatment regimen. Even with symptom improvement, premature cessation is inadvisable as complete eradication of the infection may not yet have occurred. Therefore, continue the medication as directed; therapeutic benefits may persist despite symptom resolution.
Moxgic-CV 625 Tablets may trigger allergic responses. Individuals with documented penicillin allergies should avoid this medication. Seek immediate medical attention if you experience symptoms such as hives, respiratory distress, or facial, lip, tongue, or throat swelling.
Diarrhea is a potential side effect of Moxgic-CV 625 Tablet. This antibiotic eliminates harmful bacteria; however, it can also impact beneficial gut flora, leading to diarrhea. If diarrhea occurs, increase fluid intake. Persistent diarrhea accompanied by dehydration symptoms, such as decreased urination and dark, strong-smelling urine, warrants immediate medical attention. Avoid self-medicating without consulting your physician.
Moxgic-CV 625 tablets are ineffective against viral illnesses such as influenza or the common cold. Seek professional medical advice; self-treating is inadvisable.
Moxgic-CV 625 Tablets are not expected to induce drowsiness. Report any drowsiness experienced to your physician.
Moxgic-CV 625 Tablet
176
MRP 204
13% off